Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Biogen and Sage Therapeutics Collaborate to Develop and Commercialize Potential Therapies in Depression and Movement Disorders
Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) have collaborated to develop and commercialize zuranolone and SAGE-324. Zuranolone is used to treat postpartum depression, major depressive disorder...